Your browser doesn't support javascript.
loading
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
Khanna, Reena; Bressler, Brian; Levesque, Barrett G; Zou, Guangyong; Stitt, Larry W; Greenberg, Gordon R; Panaccione, Remo; Bitton, Alain; Paré, Pierre; Vermeire, Séverine; D'Haens, Geert; MacIntosh, Donald; Sandborn, William J; Donner, Allan; Vandervoort, Margaret K; Morris, Joan C; Feagan, Brian G.
Afiliação
  • Khanna R; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Department of Medicine, University of Western Ontario, London, ON, Canada.
  • Bressler B; Department of Gastroenterology, St Paul's Hospital, Vancouver, BC, Canada.
  • Levesque BG; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
  • Zou G; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
  • Stitt LW; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada.
  • Greenberg GR; Division of Gastroenterology, Mount Sinai Hospital, Toronto, ON, Canada.
  • Panaccione R; Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Bitton A; Division of Gastroenterology, McGill University Health Centre, McGill University, Montreal, QC, Canada.
  • Paré P; Laval University, CHAUQ, Hôpital du St-Sacrement, Quebec City, QC, Canada.
  • Vermeire S; Department of Clinical and Experimental Medicine, Translational Research Center for Gastrointestinal Disorders, Leuven, Belgium.
  • D'Haens G; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Department of Gastroenterology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.
  • MacIntosh D; Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada.
  • Sandborn WJ; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
  • Donner A; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
  • Vandervoort MK; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada.
  • Morris JC; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada.
  • Feagan BG; Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Department of Medicine, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. Electronic address: brian.feagan@robartsinc.com.
Lancet ; 386(10006): 1825-34, 2015 Nov 07.
Article em En | MEDLINE | ID: mdl-26342731
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_doencas_transmissiveis Assunto principal: Doença de Crohn / Terapia de Imunossupressão Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_doencas_transmissiveis Assunto principal: Doença de Crohn / Terapia de Imunossupressão Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá